Climate Change Data

Ajanta Pharma Limited

Climate Impact & Sustainability Data (2020-04 to 2021-03, 2021-04 to 2022-03, 2022-23, 2023-24)

Reporting Period: 2020-04 to 2021-03

Environmental Metrics

ESG Focus Areas

  • Ethics, Transparency and Accountability
  • Sustainable Product Lifecycle
  • Employee Wellbeing
  • Stakeholder Engagement
  • Human Rights
  • Environmental Protection
  • Inclusive Growth
  • Customer Engagement

Environmental Achievements

  • Reduced overall fresh solvent consumption in API unit by effective recovery of solvents.
  • Treated wastewater used for maintaining green belt across the site.
  • Recycling of used plastics, HDPE drums, shippers etc.
  • Partially solid organic waste sent to cement industries for co-incineration.
  • Installed solar plants in most plants, resulting in 32 Lac kwh solar energy consumption and reduced carbon emission.
  • Installed ground mounted solar power plant at Pithampur facility, saving 50% energy charges and reducing carbon footprint.

Social Achievements

  • CSR spending of ₹12.78 cr (1.89% of profit after tax) on healthcare, education, community welfare, and COVID-19 assistance.
  • 90% of procurements sourced from domestic producers, with preference to local & MSME vendors.
  • Training programs and workshops for local and small producers.
  • Various CSR initiatives for the underprivileged sections of society and sports promotion.

Governance Achievements

  • Code of Conduct for Directors and Senior Management, extending to the group including all its employees, Directors & subsidiaries.
  • Whistleblower Policy in place.
  • Annual BR performance assessment by internal audit team.

Climate Goals & Targets

Environmental Challenges

  • No specific challenges explicitly mentioned in the report.
Mitigation Strategies
  • Developing alternate reliable vendors to ensure business continuity.
  • Implementing energy conservation projects across business units.
  • Addressing potential environmental risks through Management System approach.

Supply Chain Management

Responsible Procurement
  • Sourcing from approved vendors audited by quality assurance team.
  • Developing alternate reliable vendors.
  • Building capacity and sharing best practices amongst business partners.
  • Preference given to local & MSME vendors.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: National Voluntary Guidelines on social, environmental and economical responsibilities of business

Sustainable Products & Innovation

  • Peroduo (anti-acne)
  • Lidocam CT – Sugar free (Opioid & NSAID)
  • Duranzo (Pain Management local anesthetic)
  • Azusa T 8/40 (Antihypertensive)
  • Cardiosel OD (Antihypertensive)

Reporting Period: 2021-04 to 2022-03

Environmental Metrics

Total Carbon Emissions:51244.37 tCO2e/year
Scope 1 Emissions:4611.22 tCO2e/year
Scope 2 Emissions:46633.15 tCO2e/year
Renewable Energy Share:8% of total energy use
Total Energy Consumption:288469.46 GJ/year
Water Consumption:282129 kl/year
Waste Generated:557.63 tons/year
Carbon Intensity:0.0017 kg CO2 per rupee of turnover

ESG Focus Areas

  • Product Quality and Safety
  • Occupational Health and Safety
  • Regulatory Compliance
  • Product Innovation
  • Sustainable Supply Chain Management
  • Human Rights
  • Risk Management
  • Renewable Energy
  • Plastic Waste Management
  • Community Upliftment

Environmental Achievements

  • Recycling of 100% recyclable plastic waste.
  • Reduced 40399 Tonnes of CO2 emissions through solar plants.
  • Achieved Zero Liquid Discharge at all manufacturing plants (partially implemented).

Social Achievements

  • Conducted vaccination camps for employees and in rural areas.
  • Provided access to mental health therapists for employees.
  • Conducted hobby development sessions for employees.
  • CSR initiatives benefiting 200,000+ people in health, education, and other areas.

Governance Achievements

  • Established stringent quality control and quality assurance processes.
  • Implemented a robust grievance redressal mechanism.
  • Established Internal Complaints Committee (ICC) and Business Integrity Committee to address complaints.

Climate Goals & Targets

Medium-term Goals:
  • Enhance Renewable Energy consumption to 50% by 2026.

Environmental Challenges

  • Maintaining product quality and safety.
  • Ensuring occupational health and safety.
  • Meeting regulatory compliance requirements.
  • Sustainable supply chain management.
  • Managing risks associated with the pharmaceutical business (regulatory, competition, supply chain, cyber security, etc.).
Mitigation Strategies
  • Stringent quality control and quality assurance processes.
  • Effective health and safety management system.
  • Tracking and managing regulatory compliances.
  • Abiding by UN Charter, Universal Declaration of Human Rights, and ILO conventions.
  • Well-established risk management system including risk identification, analysis, mitigation strategies, and implementation.

Supply Chain Management

Supplier Audits: 100%

Responsible Procurement
  • Data collection on supplier certifications, SOPs, sanitation, etc. before onboarding.
  • 90% local sourcing.

Climate-Related Risks & Opportunities

Reporting Period: 2022-23

Environmental Metrics

Total Carbon Emissions:8557.87 tCO2e/year (Scope 1 & 2)
Scope 1 Emissions:4368.55 tCO2e/year
Scope 2 Emissions:51813.33 tCO2e/year
Renewable Energy Share:11%
Water Consumption:422760 m3/year
Waste Generated:2413.82 tons/year

ESG Focus Areas

  • Environment
  • Social
  • Governance

Environmental Achievements

  • Reduced coal usage by 2,493 tonnes
  • Saved 238,553 trees from cutting
  • Reduced CO2 emission by 3,364 tonnes
  • Reduced water consumption by 12,315 kl
  • Increased renewable energy share to 11% (short-term goal of 32% in next six months, 50% in two years)

Social Achievements

  • Received "Best Managed Companies for 2022" award from Deloitte
  • Received "Great Place to Work" recognition
  • Conducted largest CPR training campaign (Asia Book of Records)

Governance Achievements

  • Well-defined ESG policies implemented
  • Robust Enterprise Risk Management (ERM) framework in place
  • Robust system of internal controls

Climate Goals & Targets

Long-term Goals:
  • Achieve 100% renewable energy by 2032
Medium-term Goals:
  • Achieve 50% renewable energy by 2026
  • Reduce waste by 20% by 2026
  • Reduce water consumption by 30% by 2026
  • Become water positive by 2030
Short-term Goals:
  • Achieve 32% renewable energy in next six months
  • Achieve 50% renewable energy in two years

Environmental Challenges

  • High raw material and freight costs
  • Price erosion in the US Generics business
  • Lower demand from sponsors in the Africa Institutional business
  • Logistics challenges in Africa
  • Indian Rupee's appreciation against the Euro
Mitigation Strategies
  • Increased capital allocation to Branded Generics business
  • Accelerated product filing and enhanced ground presence
  • Focus on select high-growth potential countries
  • Enhancing field team productivity with digital tools
  • Expecting normalization of freight costs

Supply Chain Management

Responsible Procurement
  • ESG parameter-based supplier screening
  • Sourcing >90% requirements from local communities

Climate-Related Risks & Opportunities

Awards & Recognition

  • Best Managed Companies for 2022 (Deloitte)
  • Great Place to Work

Reporting Period: 2023-24

Environmental Metrics

Total Carbon Emissions:46390.96 tCO2e/year (Scope 1 & 2)
Scope 1 Emissions:6390.22 tCO2e/year
Scope 2 Emissions:40007.74 tCO2e/year
Renewable Energy Share:30%+
Water Consumption:410951 m3/year
Waste Generated:2498.57 tons/year

ESG Focus Areas

  • Clean & Green Energy Utilisation
  • Sustainability
  • Water Neutrality
  • Employee Well-being
  • Human Rights
  • Responsible Sourcing
  • Ethical Business Conduct
  • Community Welfare

Environmental Achievements

  • Commissioned a new 6.4 MW solar power plant, increasing renewable energy portfolio to 30%+ of total energy consumption. Reduced CO2 emissions by 4,200 tonnes annually.
  • Maintaining water neutrality and following a zero-discharge policy at facilities.
  • Reduced wastewater generation by 30% at Dahej plant.
  • Recycled around 40 KLD of condensate, reducing boiler fuel consumption and CO2 emission.
  • Implemented solvent waste recycling initiative.

Social Achievements

  • Launched 42 new products.
  • Added 300+ employees.
  • Enhanced promotional efforts.
  • Recognized as a 'Great Place to Work' for the second consecutive year.
  • CSR initiatives in healthcare, education, rural development, and community welfare.

Governance Achievements

  • Established robust Enterprise Risk Management (ERM) framework.
  • Implemented a comprehensive Code of Conduct for Directors and Senior Management.
  • Implemented a robust system of internal controls.
  • Complied with all applicable Secretarial Standards.

Climate Goals & Targets

Long-term Goals:
  • Net zero emissions by 2050 (implied)
Medium-term Goals:
  • Achieve 100% renewable energy by 2032.
Short-term Goals:
  • Increase renewable energy to over 50% in the next two years.
  • Reduce water consumption by 10% by 2025.
  • Reduce waste per unit of production by 10% annually and 30% by 2030.
  • Reduce energy consumption by 10% by 2026 and 15% by 2028.
  • Reduce Scope 1 and Scope 2 emissions by 10% by 2026 and 30% by 2030.

Environmental Challenges

  • Volatility in API prices and international logistics costs.
  • Tepid growth in the African market due to distributor inventory rationalisation.
  • Uncertainty in the African Institutional business due to reliance on procurement agencies' funding.
Mitigation Strategies
  • Partnered with vendors and industry experts to mitigate API price and logistics cost volatility, resulting in savings of ~₹100+ crore.
  • Improved efficiencies across functions.
  • Focused execution of strategies to grow Branded Generics business beyond normal industry growth.

Supply Chain Management

Supplier Audits: 10% upstream and 11% downstream partners (by value of business) assessed for ESG factors.

Responsible Procurement
  • Third-Party Code of Conduct covering human rights, fair employment practices, environmental sustainability, and ethical business practices.
  • Preferential procurement policy for MSMEs.

Climate-Related Risks & Opportunities

Opportunities
  • Development of energy-efficient products and processes; investment in renewable energy.

Reporting Standards

Frameworks Used: GRI, BRSR

Certifications: ISO 14001, ISO 45001

Sustainable Products & Innovation

  • Non-comedogenic dermatological formulations
  • Preservative-free ophthalmic products

Awards & Recognition

  • Apex India Safe Workplace Gold Award 2023
  • Apex India Green Leaf Platinum Award for Sustainability 2023
  • SKOCH ESG Award 2024 for Clean & Green Energy Utilisation
  • Great Place To Work® Certification